Innate Pharma Advances Toll-like Receptor Research
By Business Review Editor
Pharma Deals Review: Vol 2006 Issue 73 (Table of Contents)
Published: 6 Jul-2006
DOI: 10.3833/pdr.v2006.i73.485 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Innate Pharma is strengthening its resources in Toll-like receptor (TLR) pharmacology by entering into two strategic alliances - the acquisition of undisclosed assets from Schering-Plough and a R&D collaboration with the Institut de cancérologie Gustave-Roussy (IGR) which includes the transfer of technologies from IGR to Innate Pharma...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS